| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8623769 | Seminars in Arthritis and Rheumatism | 2018 | 14 Pages |
Abstract
CNS disease is a rare challenging complication of CVID. Patients with brain involvement are generally female, Caucasian, and likely have lung involvement. Although immunoglobulin and steroids remain the first line of treatment, other immunosuppressive agents have shown some promise with regards to recurrent relapsing presentations.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Catherine E. Najem, Jason Springer, Richard Prayson, Daniel A. Culver, James Fernandez, Jinny Tavee, Rula A. Hajj-Ali,
